Psoriatic arthritis mutilans: case series and literature review.
نویسندگان
چکیده
3. Information on permissions/orders of reprints in rheumatology and related fields. Silverman featuring research articles on clinical subjects from scientists working is a monthly international serial edited by Earl D.
منابع مشابه
Arthritis mutilans: a report from the GRAPPA 2012 annual meeting.
Arthritis mutilans is often described as the most severe form of psoriatic arthritis. However, a widely agreed on definition of the disease has not been developed. At the 2012 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members hoped to agree on a definition of arthritis mutilans and thus facilitate clinical and molecular epidemiologica...
متن کاملOpera glass hands: the phenotype of arthritis mutilans.
To cite: Ferreira MB, Sá N, Rocha SM, et al. BMJ Case Rep Published online: [please include Day Month Year] doi:10.1136/bcr-2013200035 DESCRIPTION A 51-year-old man was diagnosed with psoriatic arthritis at the age of 18. For the last 20 years he refused treatment, abandoned any follow-up and was unseen by any health professional. The patient became unable to walk 17 years ago and then went bli...
متن کاملSyddansk Universitet Disease activity in and quality of life of patients with psoriatic arthritis mutilans
متن کامل
Radiographic development during three decades in a patient with psoriatic arthritis mutilans
Psoriatic arthritis mutilans (PAM) is the most severe and rare form of psoriatic arthritis (PsA). We describe radiological development in a typical case of PAM covering three decades in order to elucidate the need for early diagnosis of PAM. Radiographs of hands and feet, taken from 1981 to 2010, were evaluated using the Psoriatic Arthritis Ratingen Score (PARS). When PsA was diagnosed, in 1981...
متن کاملPenalized regression for interval-censored times of disease progression: Selection of HLA markers in psoriatic arthritis.
Times of disease progression are interval-censored when progression status is only known at a series of assessment times. This situation arises routinely in clinical trials and cohort studies when events of interest are only detectable upon imaging, based on blood tests, or upon careful clinical examination. We consider the problem of selecting important prognostic biomarkers from a large set o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The Journal of rheumatology
دوره 40 7 شماره
صفحات -
تاریخ انتشار 2013